Whitehawk Therapeutics

Yahoo Finance • 3 months ago

Whitehawk Therapeutics GAAP EPS of -$0.26 misses by $0.33

* Whitehawk Therapeutics press release [https://seekingalpha.com/pr/20296637-whitehawk-therapeutics-reports-third-quarter-2025-financial-results-and-recent-highlights] (WHWK [https://seekingalpha.com/symbol/WHWK]): Q3 GAAP EPS of -$0.26 m... Full story

Yahoo Finance • 3 months ago

Tempus partners with Whitehawk Therapeutics to advance cancer research

[Using AI technology helps with genetic code prediction research.] Suriphon Singha/iStock via Getty Images * Tempus AI (NASDAQ:TEM [https://seekingalpha.com/symbol/TEM]) has partnered with Whitehawk Therapeutics (NASDAQ:WHWK [https://se... Full story

Yahoo Finance • 6 months ago

US Personalized Medicine Market Trends and Company Analysis Report 2025-2033 Featuring Abbott, GE, Aadi Bioscience, Illumina, QIAGEN, Eli Lilly and Co, Takeda, AbbVie, F. Hoffmann-La Roche

Company Logo The United States Personalized Medicine Market is projected to soar to US$ 307.04 billion by 2033 from US$ 169.56 billion in 2024, experiencing a CAGR of 6.82% from 2025 to 2033. Key growth drivers include advances in next-ge... Full story

Yahoo Finance • 7 months ago

Whitehawk Therapeutics to Participate in H.C. Wainwright "HCW@Home" Series

MORRISTOWN, N.J., June 19, 2025 /PRNewswire/ -- Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved ADC cancer treatments... Full story

Yahoo Finance • 8 months ago

Whitehawk Therapeutics reports annual meeting results

Whitehawk Therapeutics, Inc. (NASDAQ:WHWK), a pharmaceutical company with a market capitalization of $94 million, announced the outcomes of its annual stockholders’ meeting held on June 11, 2025. According to InvestingPro analysis, the com... Full story